Erytech Pharma SA bags US$57m from SQZ Biotechnologies
Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to develop new immune modulating therapies.
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1163 entries already.
Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to develop new immune modulating therapies.
Sanofis and Regenerons IL-33 blocker REGN3500 met primary Phase II endpoint in asthma patients.
Karo Pharma AB announced it will acquire Trimb Holding AB for MSEK3,400 (319.6m) and intends to carry out a Rights Issue of about MSEK 1,500 (141m).
German GM proponents have taken action against discrimination of food products generated by gene editing.
Researchers from Israel and the UK have identified how the cytokine IL-23 triggers inflammatory bowel syndrome (IBD), which affects 1.6 million patients annually in the US alone.
Scientists from the University of Washington are using the Phenoglyphs machine learning module to achieve faster high-content analysis through automation and simplification.
German and US researchers have developed a diagnostic technique capable to detect one single circulating tumour cell in one litre of blood.
Swiss antibody drug conjugate developer ADC Therapeutics SA raised $76m, bringing the total gross proceeds to $276 million in its Series E financing.
The Bill & Melinda Gates Foundation has granted Evotec SE $23.8m to identify the best drug combos to fight tuberculosis.
The cells surrounding structures play an important role as cues from the immune system in guiding their motility and behaviour, researchers from the UK and the US report.